Immediate Impact
66 hit
Citing Papers
Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn’s Disease: Results From the Phase 3 GRAVITI Study
2025 Hit
Chronic kidney disease–mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
2025 Hit
Works of Axel Svedbom being referenced
The Osteoporosis Treatment Gap
2014
Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX algorithm
2013
Author Peers
Peers are selected by citation overlap in the author's most active subfields. citations · hero ref
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Axel Svedbom | 350 | 345 | 217 | 186 | 129 | 54 | 971 | |
| Natalie Boytsov | 283 0.8× | 266 0.8× | 85 0.4× | 281 1.5× | 98 0.8× | 44 | 879 | |
| H Awada | 257 0.7× | 295 0.9× | 129 0.6× | 503 2.7× | 53 0.4× | 37 | 1.1k | |
| M. Larrosa | 200 0.6× | 162 0.5× | 185 0.9× | 526 2.8× | 77 0.6× | 63 | 985 | |
| Laura D. Carbone | 361 1.0× | 424 1.2× | 137 0.6× | 294 1.6× | 178 1.4× | 52 | 1.1k | |
| Asgar Ali Kalla | 195 0.6× | 160 0.5× | 70 0.3× | 315 1.7× | 78 0.6× | 42 | 815 | |
| Adriana María Kakehasi | 121 0.3× | 135 0.4× | 226 1.0× | 440 2.4× | 117 0.9× | 101 | 1.0k | |
| Gabor Major | 206 0.6× | 285 0.8× | 198 0.9× | 407 2.2× | 185 1.4× | 41 | 904 | |
| Michele Intorcia | 257 0.7× | 95 0.3× | 132 0.6× | 276 1.5× | 123 1.0× | 39 | 867 | |
| Ira Pande | 173 0.5× | 171 0.5× | 150 0.7× | 373 2.0× | 89 0.7× | 42 | 919 | |
| S. Radominski | 141 0.4× | 77 0.2× | 245 1.1× | 495 2.7× | 112 0.9× | 54 | 963 |
All Works
Loading papers...